What is PRP? (2min)

PRP In Detail: Oldie but Goodie (19min)

PH Balance Spectrum

Regenkit vs Arthrex ACP

Types of Growth Factors

Finished PRP

Regentkit Advantage

  • PRP, PRP-LR, PRP-LP, PRF options
  • Leukocyte Rich and Leukocyte Poor versions available
  • Highest PRP Yield per Blood Draw on the market
  • 8-10mls blood yields 4-5ccs PRP
  • As little as 5 minute processing time
  • Convenience kits available
  • Automatic Blood Draw
  • Automatic Platelet Separation
  • Adjustable concentration 1.7 to 5x over baseline
  • Up to 99.7% RBC removal (bct version)

 

The RegenKit THT Autologous Platelet-rich Plasma (A-PRP) system aids in the separation of the patient’s own blood components through the use of the RegenKit THT vacuum tube and clinical centrifuge. RegenKit THT A-PRP is designed to deliver an increased concentration of bioactive factors and proteins through the concentration of platelets from whole blood. Once the blood is drawn into the RegenKit THT vacuum tube it is then spun under centrifugation according to centrifuge operating instructions. The PRP prepared using the RegenKit THT is a platelet-rich plasma preparation with high platelet recovery and viability, a physiological level of leukocytes, and contains the entire plasma component of blood, which is rich in growth factors. The platelet–rich plasma is collected with syringes and can be mixed during application at the patient’s point of care.

Indications for Use

RegenKit-THT is designed to be used for the safe a rapid perparation of autologous platelet rich-rich plasma (A-PRP) from a small sample of blood at the patient’s point of care. The PRP is mixed with autograft and/or allograft bone prior to application to an orthopaedic surgical site, as deemed necessary by clinical use requirements.

Frequently Asked Questions by Reps

Frequently Asked Questions by Customers

Handling Objections

Competitive Systems

Arthrex ACP (Autologous Conditioned Plasma)

Arthrex ACP (3min)

Available in Single Dual Syringe , Single Kit , Double Kit.

15cc Blood Draw. 3cc PRP Yield. 5 min Spin. Manual Blood Draw -futzy compared to pressurized vacutainer. Manual Separation- prone to error, not getting enough platelets on buffy coat or getting too much RBCs. Most likely seen on orthopedics due to Arthrex relationship.

Sell against: We draw less blood (8cc) and give more prp (5-6cc).

Deep dive: With standard processing ACP has higher concentration, but Regen has greater amount of platelets. Regen can be manipulated to have a higher concentration.

Eclipse 11 and 22

Eclipse 22 (3min)

Eclipse 11 (4min)

11 and 22cc. 10 min spin. System almost identical to Regenlab. Heavy in Aesthetic Market.

Tropocells

Tropocells (5min)

Product Info

 

References

  1. Lin MD, et al., Intra-articular Injection of Platelet-Rich Plasma Is Superior to Hyaluronic Acid or Saline Solution in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized, Double-Blind, Triple-Parallel, Placebo-Controlled Clinical Trial. Journal of Arthroscopic and Related Suregery, January, 2019, Volume 35, Issue 1, Pages 106–117.
  2. Study Report – Regen™ THT Tube Performance Testing, USFDA 510(k) BK090048, May 2010, Data on file at RegenLab, Switzerland.
  3. Kevy, et al., “Comparison of Methods for Point of Care Preparation of Autologous Platelet Gel”. JECT 36:p. 28 (2004).
  4. S. Arnoczky, “What is Platelet-rich Plasma (PRP)”. AAOS Now 2001 PRP Forum - Agenda and Background Materials, February 14, 2011.
  5. Foster T et al., “Platelet-Rich Plasma - From Basic Science to Clinical Applications”. AJSM 37 (11), p. 2259 (2009).
  6. Platelets, Second Edition, Alan D. Michelson Editor, Elsevier (2007).
  7. Cieslik-Bielecka et al., “Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury”. Transfusion and Apheresis Science 41, p. 9 (2009).
  8. Clark, “Fibrin and Wound Healing”. Annals of New York Academy of Sciences, p. 355 (2001).
  9. 1. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–439. [PubMed[]
  10. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37:2259–2272. [PubMed[]
  11. Le A, Dragoo JL. Orthobiologics: clinical application of platelet-rich plasma and stem cell therapy. DeLee Drezs Orthop Sports Med. 5th Edition. Elsevier; XXXX p XXX.
  12. • Le AD, Enweze L, DeBaun MR, Dragoo JL. Platelet-rich plasma. Clin Sports Med. 2018;XX:XX–XX. Recent (in-press) comprehensive review of PRP literature outlining best available clinical evidence as well as pre-clinical evidence, where appropriate, for a variety of sports medicine applications.
  13. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10:225–228. [PubMed[]
  14. Degen RM, Bernard JA, Oliver KS, Dines JS. Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition. HSS J. 2017;13:75–80. [PMC free article] [PubMed[]
  15. Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J, Magalon G, Dignat-Georges F, Sabatier F. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 2014;30:629–638. [PubMed[]
  16. Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39:266–271. [PubMed[]
  17. Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, Arnoczky SP. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012;40:1274–1281. [PubMed[]
  18. Mazzocca AD, McCarthy MBR, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308–316. [PubMed[]
  19. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39:2135–2140. [PubMed[]
  20. Boesen AP, Hansen R, Boesen MI, Malliaras P, Langberg H. Effect of high-volume injection, platelet-rich plasma, and sham treatment in chronic midportion achilles tendinopathy: a randomized double-blinded prospective study. Am J Sports Med. 2017;45:2034–2043. [PubMed[]
  21. Krogh TP, Ellingsen T, Christensen R, Jensen P, Fredberg U. Ultrasound-guided injection therapy of Achilles tendinopathy with platelet-rich plasma or saline: a randomized, blinded, placebo-controlled trial. Am J Sports Med. 2016;44:1990–1997. [PubMed[]
  22. Behera P, Dhillon M, Aggarwal S, Marwaha N, Prakash M. Leukocyte-poor platelet-rich plasma versus bupivacaine for recalcitrant lateral epicondylar tendinopathy. J Orthop Surg. 2015;23:6–10. [PubMed[]
  23. Gautam V, Verma S, Batra S, Bhatnagar N, Arora S. Platelet-rich plasma versus corticosteroid injection for recalcitrant lateral epicondylitis: clinical and ultrasonographic evaluation. J Orthop Surg. 2015;23:1–5. [PubMed[]
  24. Lebiedziński R, Synder M, Buchcic P, Polguj M, Grzegorzewski A, Sibiński M. A randomized study of autologous conditioned plasma and steroid injections in the treatment of lateral epicondylitis. Int Orthop. 2015;39:2199–2203. [PubMed[]
  25. Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42:463–471. [PubMed[]
  26. Montalvan B, Le Goux P, Klouche S, Borgel D, Hardy P, Breban M. Inefficacy of ultrasound-guided local injections of autologous conditioned plasma for recent epicondylitis: results of a double-blind placebo-controlled randomized clinical trial with one-year follow-up. Rheumatology. 2016;55:279–285. [PubMed[]
  27. Palacio EP, Schiavetti RR, Kanematsu M, Ikeda TM, Mizobuchi RR, Galbiatti JA. Effects of platelet-rich plasma on lateral epicondylitis of the elbow: prospective randomized controlled trial. Rev Bras Ortop Engl Ed. 2016;51:90–95. [PMC free article] [PubMed[]
  28. Yadav R. Comparison of local injection of platelet rich plasma and corticosteroids in the treatment of lateral epicondylitis of humerus. J Clin Diagn Res [Internet]. 2015 [cited 2018 Apr 2]; Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2015&volume=9&issue=7&page=RC05&issn=0973-709x&id=6213[PMC free article] [PubMed]
  29. Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med. 2014;42:610–618. [PubMed[]
  30. Vetrano M, Castorina A, Vulpiani MC, Baldini R, Pavan A, Ferretti A. Platelet-rich plasma versus focused shock waves in the treatment of Jumper’s knee in athletes. Am J Sports Med. 2013;41:795–803. [PubMed[]
  31. Acosta-Olivo C, Elizondo-Rodriguez J, Lopez-Cavazos R, Vilchez-Cavazos F, Simental-Mendia M, Mendoza-Lemus O. Plantar fasciitis—a comparison of treatment with intralesional steroids versus platelet-rich plasma: a randomized, blinded study. J Am Podiatr Med Assoc. 2017;107:490–496. [PubMed[]
  32. Jain K, Murphy PN, Clough TM. Platelet rich plasma versus corticosteroid injection for plantar fasciitis: a comparative study. Foot. 2015;25:235–237. [PubMed[]
  33. Jain Sumit Kumar, Suprashant Kumar, Kumar Sanjeev, Yadav Arun, Kearns Stephen R. Comparison of Plantar Fasciitis Injected With Platelet-Rich Plasma vs Corticosteroids. Foot & Ankle International. 2018;39(7):780–786. [PubMed[]
    26. Mahindra P, Yamin M, Selhi HS, Singla S, Soni A. Chronic plantar fasciitis: effect of platelet-rich plasma, corticosteroid, and placebo. Orthopedics. 2016;39:e285–e289. [PubMed[]
  34. Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int. 2014;35:313–318. [PubMed[]
  35. Say F, Gürler D, İnkaya E, Bülbül M. Comparison of platelet-rich plasma and steroid injection in the treatment of plantar fasciitis. Acta Orthop Traumatol Turc. 2014;48:667–672. [PubMed[]
  36. Sherpy NA, Hammad MA, Hagrass HA, Samir H, Abu-ElMaaty SE, Mortada MA. Local injection of autologous platelet rich plasma compared to corticosteroid treatment of chronic plantar fasciitis patients: a clinical and ultrasonographic follow-up study. Egypt Rheumatol. 2016;38:247–252. []
  37. Shetty VD, Dhillon M, Hegde C, Jagtap P, Shetty S. A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis: a preliminary report. Foot Ankle Surg. 2014;20:10–13. [PubMed[]
  38. Tiwari M, Bhargava R. Platelet rich plasma therapy: a comparative effective therapy with promising results in plantar fasciitis. J Clin Orthop Trauma. 2013;4:31–35. [PMC free article] [PubMed[]
  39. Vahdatpour B, Kianimehr L, Moradi A, Haghighat S. Beneficial effects of platelet-rich plasma on improvement of pain severity and physical disability in patients with plantar fasciitis: a randomized trial. Adv Biomed Res. 2016;5:179. [PMC free article] [PubMed[]
  40. Kesikburun S, Tan AK, Yılmaz B, Yaşar E, Yazıcıoğlu K. Platelet-rich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1-year follow-up. Am J Sports Med. 2013;41:2609–2616. [PubMed[]
  41. Rha D, Park G-Y, Kim Y-K, Kim MT, Lee SC. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil. 2013;27:113–122. [PubMed[]
  42. Shams A, El-Sayed M, Gamal O, Ewes W. Subacromial injection of autologous platelet-rich plasma versus corticosteroid for the treatment of symptomatic partial rotator cuff tears. Eur J Orthop Surg Traumatol. 2016;26:837–842. [PubMed[]
  43. Miller LE, Parrish WR, Roides B, Bhattacharyya S. Efficacy of platelet-rich plasma injections for symptomatic tendinopathy: systematic review and meta-analysis of randomised injection-controlled trials. BMJ Open Sport Exerc Med. 2017;3:e000237. [PMC free article] [PubMed[]
  44. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39:1200–1208. [PubMed[]
  45. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38:255–262. [PubMed[]
  46. Arirachakaran A, Sukthuayat A, Sisayanarane T, Laoratanavoraphong S, Kanchanatawan W, Kongtharvonskul J. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis. J Orthop Traumatol. 2016;17:101–112. [PMC free article] [PubMed[]
  47. Krogh TP, Bartels EM, Ellingsen T, Stengaard-Pedersen K, Buchbinder R, Fredberg U, Bliddal H, Christensen R. Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med. 2013;41:1435–1446. [PubMed[]
  48. de Vos RJ, Weir A, Tol JL, Verhaar JAN, Weinans H, van Schie HTM. No effects of PRP on ultrasonographic tendon structure and neovascularisation in chronic midportion Achilles tendinopathy. Br J Sports Med. 2011;45:387–392. [PubMed[]
  49. de Jonge S, de Vos RJ, Weir A, van Schie HTM, Bierma-Zeinstra SMA, Verhaar JAN, Weinans H, Tol JL. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011;39:1623–1629. [PubMed[]
  50. Neufeld SK, Cerrato R. Plantar fasciitis: evaluation and treatment. J Am Acad Orthop Surg. 2008;16:338–346. [PubMed[]
  51. Yang W-Y, Han Y-H, Cao X-W, Pan J-K, Zeng L-F, Lin J-T, et al. Platelet-rich plasma as a treatment for plantar fasciitis: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 2017;96:e8475. [PMC free article] [PubMed[]
  52. Singh P, Madanipour S, Bhamra JS, Gill I. A systematic review and meta-analysis of platelet-rich plasma versus corticosteroid injections for plantar fasciopathy. Int Orthop. 2017;41:1169–1181. [PubMed[]
  53. Barber FA. Triple-loaded single-row versus suture-bridge double-row rotator cuff tendon repair with platelet-rich plasma fibrin membrane: a randomized controlled trial. Arthroscopy. 2016;32:753–761. [PubMed[]
  54. Jo CH, Shin JS, Shin WH, Lee SY, Yoon KS, Shin S. Platelet-rich plasma for arthroscopic repair of medium to large rotator cuff tears: a randomized controlled trial. Am J Sports Med. 2015;43:2102–2110. [PubMed[]
  55. Pandey V, Bandi A, Madi S, Agarwal L, Acharya KKV, Maddukuri S, Sambhaji C, Willems WJ. Does application of moderately concentrated platelet-rich plasma improve clinical and structural outcome after arthroscopic repair of medium-sized to large rotator cuff tear? A randomized controlled trial. J Shoulder Elb Surg. 2016;25:1312–1322. [PubMed[]
  56. Saltzman BM, Jain A, Campbell KA, Mascarenhas R, Romeo AA, Verma NN, Cole BJ. Does the use of platelet-rich plasma at the time of surgery improve clinical outcomes in arthroscopic rotator cuff repair when compared with control cohorts? A systematic review of meta-analyses. Arthroscopy. 2016;32:906–918. [PubMed[]
    50. Holtby R, Christakis M, Maman E, MacDermid JC, Dwyer T, Athwal GS, et al. Impact of platelet-rich plasma on arthroscopic repair of small- to medium-sized rotator cuff tears: a randomized controlled trial. Orthop J Sports Med. 2016;4:232596711666559. [PMC free article] [PubMed[]
  57. Ebert JR, Wang A, Smith A, Nairn R, Breidahl W, Zheng MH, Ackland T. A midterm evaluation of postoperative platelet-rich plasma injections on arthroscopic supraspinatus repair: a randomized controlled trial. Am J Sports Med. 2017;45:2965–2974. [PubMed[]
  58. Malavolta EA, Gracitelli MEC, Ferreira Neto AA, Assunção JH, Bordalo-Rodrigues M, de Camargo OP. Platelet-rich plasma in rotator cuff repair: a prospective randomized study. Am J Sports Med. 2014;42:2446–2454. [PubMed[]
  59. D’Ambrosi R, Palumbo F, Paronzini A, Ragone V, Facchini RM. Platelet-rich plasma supplementation in arthroscopic repair of full-thickness rotator cuff tears: a randomized clinical trial. Musculoskelet Surg. 2016;100:25–32. [PubMed[]
  60. Flury M, Rickenbacher D, Schwyzer H-K, Jung C, Schneider MM, Stahnke K, Goldhahn J, Audigé L. Does pure platelet-rich plasma affect postoperative clinical outcomes after arthroscopic rotator cuff repair?: a randomized controlled trial. Am J Sports Med. 2016;44:2136–2146. [PubMed[]
  61. Cai Y, Zhang C, Lin X. Efficacy of platelet-rich plasma in arthroscopic repair of full-thickness rotator cuff tears: a meta-analysis. J Shoulder Elb Surg. 2015;24:1852–1859. [PubMed[]
    56. Filardo G, Di Matteo B, Kon E, Merli G, Marcacci M. Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surg Sports Traumatol Arthrosc [Internet]. 2016 [cited 2018 Mar 14]; Available from: http://link.springer.com/10.1007/s00167-016-4261-4
  62.  Smith KM, Le A, Costouros J, Dragoo JL. Biologics for rotator cuff repair: a critical analysis review. JBJS Rev. 2018;XX:XX–XX. Recent review on use of biologic augmentation for rotator cuff repair. Review concluded that PRP did not demonstrate efficacy as an adjuvant in rotator cuff repair. Subgroup analyses did reveal decreased re-tear rate with PRP augmentation in small and medium tears treated with arthroscopic double-row repair.
  63. Vavken P, Sadoghi P, Palmer M, Rosso C, Mueller AM, Szoelloesy G, Valderrabano V. Platelet-rich plasma reduces retear rates after arthroscopic repair of small- and medium-sized rotator cuff tears but is not cost-effective. Am J Sports Med. 2015;43:3071–3076. [PubMed[]
  64.  Allahverdi A, Sharifi D, Takhtfooladi MA, Hesaraki S, Khansari M, Dorbeh SS. Evaluation of low-level laser therapy, platelet-rich plasma, and their combination on the healing of Achilles tendon in rabbits. Lasers Med Sci. 2015;30:1305–1313. [PubMed[]
  65. Yuksel S, Gulec MA, Gultekin MZ, Adanir O, Caglar A, Beytemur O, et al. Comparison of the early period effects of bone marrow-derived mesenchymal stem cells and platelet-rich plasma on the Achilles tendon ruptures in rats. Connect Tissue Res. 2016;57:360–373. [PubMed[]
  66. Aspenberg P. Platelet concentrates and Achilles tendon healing. J Orthop Res. 2013;31:1500. [PubMed[]
  67. De Carli A, Lanzetti RM, Ciompi A, Lupariello D, Vadala A, Argento G, et al. Can platelet-rich plasma have a role in Achilles tendon surgical repair? Knee Surg Sports Traumatol Arthrosc. 2016;24:2231–2237. [PubMed[]
  68. Zou J, Mo X, Shi Z, Li T, Xue J, Mei G, et al. A prospective study of platelet-rich plasma as biological augmentation for acute Achilles tendon rupture repair. Biomed Res Int. 2016;2016:1–8. [PMC free article] [PubMed[]
  69. Di Matteo B, Loibl M, Andriolo L, Filardo G, Zellner J, Koch M, et al. Biologic agents for anterior cruciate ligament healing: a systematic review. World J Orthop. 2016;7:592–603. [PMC free article] [PubMed[]
  70. Sánchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy. 2010;26:470–480. [PubMed[]
  71. Vogrin M, Rupreht M, Dinevski D, Hašpl M, Kuhta M, Jevsek M, et al. Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind, clinical trial. Eur Surg Res. 2010;45:77–
  72. 67. Andriolo L, Di Matteo B, Kon E, Filardo G, Venieri G, Marcacci M. PRP augmentation for ACL reconstruction. Biomed Res Int. 2015;2015:1–15. [PMC free article] [PubMed[]
  73. Figueroa D, Melean P, Calvo R, Vaisman A, Zilleruelo N, Figueroa F, Villalón I. Magnetic resonance imaging evaluation of the integration and maturation of semitendinosus-gracilis graft in anterior cruciate ligament reconstruction using autologous platelet concentrate. Arthroscopy. 2010;26:1318–1325. [PubMed[]
  74. Mirzatolooei F, Alamdari MT, Khalkhali HR. The impact of platelet-rich plasma on the prevention of tunnel widening in anterior cruciate ligament reconstruction using quadrupled autologous hamstring tendon. Bone Joint J. 2013;95–B:65–69. [PubMed[]
  75. Seijas R, Cuscó X, Sallent A, Serra I, Ares O, Cugat R. Pain in donor site after BTB-ACL reconstruction with PRGF: a randomized trial. Arch Orthop Trauma Surg. 2016;136:829–835. [PubMed[]
  76.  Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005;24:1–12. [PubMed[]
  77. Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R, Giannini S. Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics. 2013;36:e1501–e1508. [PubMed[]
  78. Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P, Tschon M, Giavaresi G. Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. Am J Sports Med. 2016;44:664–671. [PubMed[]
  79. ultrasound-guided platelet rich plasma versus hyaluronic acid injections in a randomized clinical trial. Joints. 2017;5:152–155. [PMC free article] [PubMed[]
    75. Sante LD, Villani C, Santilli V, Valeo M, Bologna E, Imparato L, Paoloni M, Iagnocco A. Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis. Med Ultrason. 2016;18:463–468. [PubMed[]
  80. Cole BJ, Karas V, Hussey K, Merkow DB, Pilz K, Fortier LA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2017;45:339–346. [PubMed[]
  81. Duymus TM, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas FN. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surg Sports Traumatol Arthrosc. 2017;25:485–492. [PubMed[]
  82. Görmeli G, Görmeli CA, Ataoglu B, Çolak C, Aslantürk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2017;25:958–965. [PubMed[]
  83. Lana JFSD, Weglein A, Sampson SE, Vicente EF, Huber SC, Souza CV, Ambach MA, Vincent H, Urban-Paffaro A, Onodera CM, Annichino-Bizzacchi JM, Santana MH, Belangero WD. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med. 2016;12:69–78. [PMC free article] [PubMed[]
  84. Montañez-Heredia E, Irízar S, Huertas PJ, Otero E, del Valle M, Prat I, et al. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the Spanish National Health Care System. Int J Mol Sci [Internet]. 2016 [cited 2018 Mar 12];17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964440/[PMC free article] [PubMed]
  85. Paterson KL, Nicholls M, Bennell KL, Bates D. Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study. BMC Musculoskelet Disord [Internet]. 2016 [cited 2018 Mar 12];17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748460/[PMC free article] [PubMed]
  86. Simental-Mendía M, Vílchez-Cavazos JF, Peña-Martínez VM, Said-Fernández S, Lara-Arias J, Martínez-Rodríguez HG. Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016;136:1723–1732. [PubMed[]
  87. Smith PA. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med. 2016;44:884–891. [PubMed[]
  88. Vaquerizo V, Plasencia MÁ, Arribas I, Seijas R, Padilla S, Orive G, Anitua E. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013;29:1635–1643. [PubMed[]
  89.  • Shen L, Yuan T, Chen S, Xie X, Zhang C. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg [Internet]. 2017 [cited 2017 Jul 8];12. Available from: http://josr-online.biomedcentral.com/articles/10.1186/s13018-017-0521-3Recent systematic review and meta-analysis of RCTs evaluating PRP for knee OA. Intra-articular PRP injections appear to be superior in treating pain relief and function symptoms of OA at 3, 6, and 12 months follow-up, compared with other injections, including saline placebo, HA, ozone, and corticosteroids.
  90. Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2016;44:792–800. [PubMed[]
  91. Cerza F, Carnì S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40:2822–2827. [PubMed[]
    88. Sánchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, Albillos J, Gárate R, Aguirre JJ, Padilla S, Orive G, Anitua E. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28:1070–1078. [PubMed[]
  92. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41:356–364. [PubMed[]
  93. Hart R, Safi A, Komzák M, Jajtner P, Puskeiler M, Hartová P. Platelet-rich plasma in patients with tibiofemoral cartilage degeneration. Arch Orthop Trauma Surg. 2013;133:1295–1301. [PubMed[]
  94. Filardo G, Di Matteo B, Di Martino A, Merli ML, Cenacchi A, Fornasari P, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med. 2015;43:1575–1582. [PubMed[]
  95. Civinini R, Nistri L, Martini C, Redl B, Ristori G, Innocenti M. Growth factors in the treatment of early osteoarthritis. Clin Cases Miner Bone Metab. 2013;10:26–29. [PMC free article] [PubMed[]
  96. Carballo CB, Nakagawa Y, Sekiya I, Rodeo SA. Basic science of articular cartilage. Clin Sports Med. 2017;36:413–425. [PubMed[]
  97. Rayegani SM, Raeissadat SA, Taheri MS, Babaee M, Bahrami MH, Eliaspour D, et al. Does intra articular platelet rich plasma injection improve function, pain and quality of life in patients with osteoarthritis of the knee? A randomized clinical trial. Orthop Rev [Internet]. 2014 [cited 2018 Mar 12];6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195987/[PMC free article] [PubMed]
  98.  Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human s implications for intra-articular injury and therapy. Am J Sports Med. 2014;42:1204–1210. [PMC free article] [PubMed[]
  99.  Rowden A, Dominici P, D’Orazio J, Manur R, Deitch K, Simpson S, et al. Double-blind, randomized, placebo-controlled study evaluating the use of platelet-rich plasma therapy (PRP) for acute ankle sprains in the emergency department. J Emerg Med. 2015;49:546–551. [PubMed[]
  100. Laver L, Carmont MR, McConkey MO, Palmanovich E, Yaacobi E, Mann G, et al. Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial. Knee Surg Sports Traumatol Arthrosc. 2015;23:3383–3392. [PubMed[]
  101. Actions for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med. 2014;42:2410–2418. [PubMed[]
    99. Reurink G, Goudswaard GJ, Moen MH, Weir A, Verhaar JAN, Bierma-Zeinstra SMA, Maas M, Tol JL, Dutch Hamstring Injection Therapy (HIT) Study Investigators Platelet-rich plasma injections in acute muscle injury. N Engl J Med. 2014;370:2546–2547. [PubMed[]
  102. Marcazzan S, Taschieri S, Weinstein RL, Del Fabbro M. Efficacy of platelet concentrates in bone healing: a systematic review on animal studies—part B: large-size animal models. Platelets. 2017;1–9. [PubMed]
  103. Dulgeroglu TC, Metineren H. Evaluation of the effect of platelet-rich fibrin on long bone healing: an experimental rat model. Orthopedics. 2017;40:e479–e484. [PubMed[]
  104. Gianakos A, Zambrana L, Savage-Elliott I, Lane JM, Kennedy JG. Platelet-rich plasma in the animal long-bone model: an analysis of basic science evidence. Orthopedics. 2015;38:e1079–e1090. [PubMed[]
  105. Guzel Y, Karalezli N, Bilge O, Kacira BK, Esen H, Karadag H, Toker S, Göncü RG, Doral MN. The biomechanical and histological effects of platelet-rich plasma on fracture healing. Knee Surg Sports Traumatol Arthrosc. 2015;23:1378–1383. [PubMed[]
    104. Roffi A, Di Matteo B, Krishnakumar GS, Kon E, Filardo G. Platelet-rich plasma for the treatment of bone defects: from pre-clinical rational to evidence in the clinical practice. A systematic review. Int Orthop. 2017;41:221–237. [PubMed[]

Our other biologic product categories...

Acellular Dermal Matrix

Adipose Tissue Treatment

Platelet Rich Plasma

Synthetic Grafts

Wharton's Jelly / Umbilical Cord

Cartilage Repair

Tissue and Bone Banks

Learn more about our products...